DigitalKush: made some biography v1...

2026-02-22T19:24:47Z

made some biography v1...

New page

{{Short description|American scientist}}
{{resume-like|date=August 2025}}
{{Infobox academic
| title = Carl Ring Family Professor
| image = Ankur Singh, Professor, Georgia Tech.jpg
| caption =
| birth_place = [[Varanasi]], India
| alma_mater = [[Georgia Institute of Technology]] <br> [[The University of Texas at Austin]]<br>
[[Indian Institute of Technology Bombay]]
| known_for = Human Immune Organoids, Biomaterials, Lymphoma and Cancer Technologies
| discipline = [[Biomedical engineering]]
| sub_discipline = [[immunology|Immune]] and [[tissue engineering]], [[nanomaterials]] and [[biomaterials]], [[vaccines]]
| employer = [[Georgia Institute of Technology]]
[[Cornell University]]
}}
'''Ankur Singh''' ([[Hindi]]: अंकुर सिंह) is an [[Indian Americans|Indian-American]] [[Biomedical engineering|biomedical engineer]] and scientist whose research focuses on engineering [[immune system]]. He is a Carl Ring Family Endowed Professor at [[Georgia Tech|Georgia Institute of Technology]] in the [[George W. Woodruff School of Mechanical Engineering]] and [[Wallace H. Coulter Department of Biomedical Engineering]].<ref>{{Cite web |title=Ankur_Singh_me |url=https://www.me.gatech.edu/faculty/singh |access-date=2024-09-02 |website=www.me.gatech.edu }}</ref><ref>{{Cite web |title=Faculty Profile {{!}} Coulter Department of Biomedical Engineering |url=https://bme.gatech.edu/bme/faculty/Ankur-Singh |access-date=2024-09-02 |website=bme.gatech.edu}}</ref> He serves as the director of the Center for Immunoengineering at [[Georgia Tech]].<ref>{{Cite web |title=Center for Immunoengineering at Georgia Tech – Just another Sites @ Georgia Tech site |url=https://immunoengineering.gatech.edu/ |access-date=2024-09-02 |website=immunoengineering.gatech.edu}}</ref>

== Education and work ==
Singh completed his PhD in [[Biomedical engineering|Biomedical Engineering]] at [[University of Texas at Austin|The University of Texas at Austin]] in 2010,<ref>{{Cite web |title=Ankur Singh, Ph.D. 2010 - Department of Biomedical Engineering |url=https://bme.utexas.edu/connect/alumni-profiles/ankur-singh-phd-10 |access-date=2024-09-02 |website=bme.utexas.edu}}</ref> working with leading biomedical scientist, Krishnendu Roy, now Dean of Engineering at [[Vanderbilt University]].<ref>{{Cite web |date=April 17, 2023 |title=Vanderbilt names esteemed biomedical engineer Krishnendu Roy as next dean of School of Engineering |url=https://news.vanderbilt.edu/2023/04/17/vanderbilt-names-esteemed-biomedical-engineer-krishnendu-roy-as-next-dean-of-school-of-engineering/ |access-date=2024-09-02 |website=Vanderbilt University }}</ref> His doctoral thesis focused on bioengineered [[immunotherapy]] where he led the development of an injectable, in situ crosslinkable [[hydrogel]] - [[microparticle]] [[vaccine]] formulation to attract [[dendritic cell]]s to the site of injection and bias [[T cell]] immune response against infection and [[lymphoma]] cancer.<ref>{{Cite journal |last1=Singh |first1=Ankur |last2=Nie |first2=Hui |last3=Ghosn |first3=Bilal |last4=Qin |first4=Hong |last5=Kwak |first5=Larry W. |last6=Roy |first6=Krishnendu |date=December 2008 |title=Efficient modulation of T-cell response by dual-mode, single-carrier delivery of cytokine-targeted siRNA and DNA vaccine to antigen-presenting cells |journal=Molecular Therapy: The Journal of the American Society of Gene Therapy |volume=16 |issue=12 |pages=2011–2021 |doi=10.1038/mt.2008.206 |issn=1525-0024 |pmid=18813280|doi-access=free }}</ref><ref name="auto">{{Cite journal |last1=Singh |first1=Ankur |last2=Suri |first2=Shalu |last3=Roy |first3=Krishnendu |date=October 2009 |title=In-situ crosslinking hydrogels for combinatorial delivery of chemokines and siRNA-DNA carrying microparticles to dendritic cells |journal=Biomaterials |volume=30 |issue=28 |pages=5187–5300 |doi=10.1016/j.biomaterials.2009.06.001 |issn=0142-9612 |pmc=2818033 |pmid=19560815}}</ref> The combinatorial vaccine was among the early works to demonstrate the co-delivery of [[Chemotaxis|chemoattractants]], [[DNA]], and [[Small interfering RNA|siRNA]] to the same immune cell.<ref name="auto"/>

Singh immigrated to the United States in 2006 following a Master of Technology in biomedical engineering from the [[IIT Bombay|Indian Institute of Technology-Bombay]], and a Bachelor of Engineering in [[biochemical engineering]] from [[Kumaun University|Kumaon University]], India. His master's thesis at IIT-Bombay focused on studying [[lipid]] [[nanoparticle]]s for cancer treatment, working with Rinti Banerjee.<ref>{{Cite journal |last1=Joshi |first1=Nitin |last2=Shirsath |first2=Nitesh |last3=Singh |first3=Ankur |last4=Joshi |first4=Kalpana S. |last5=Banerjee |first5=Rinti |date=2014-11-18 |title=Endogenous lung surfactant inspired pH responsive nanovesicle aerosols: pulmonary compatible and site-specific drug delivery in lung metastases |journal=Scientific Reports |volume=4 |article-number=7085 |doi=10.1038/srep07085 |issn=2045-2322 |pmc=4235800 |pmid=25403950|bibcode=2014NatSR...4.7085J }}</ref>

Singh completed his postdoctoral training with bioengineering pioneer Andrés J. García and was co-advised by stem cell expert Todd McDevitt at Georgia Institute of Technology (2010–2013). His postdoctoral research, reported in [[Nature Methods]], developed a first microfluidics platform for adhesion strength–based, label-free isolation of human induced [[Induced pluripotent stem cell|pluripotent stem cells]].<ref>{{Cite journal |last1=Abilez |first1=Oscar J. |last2=Wu |first2=Joseph C. |date=June 2013 |title=Differential stickiness |url=https://www.nature.com/articles/nmat3664 |journal=Nature Materials |volume=12 |issue=6 |pages=474–476 |doi=10.1038/nmat3664 |pmid=23695740 |bibcode=2013NatMa..12..474A |issn=1476-4660|url-access=subscription }}</ref><ref name=":0">{{Cite journal |last1=Singh |first1=Ankur |last2=Suri |first2=Shalu |last3=Lee |first3=Ted |last4=Chilton |first4=Jamie M |last5=Cooke |first5=Marissa T |last6=Chen |first6=Weiqiang |last7=Fu |first7=Jianping |last8=Stice |first8=Steven L |last9=Lu |first9=Hang |last10=McDevitt |first10=Todd C |last11=García |first11=Andrés J |date=May 2013 |title=Adhesion strength–based, label-free isolation of human pluripotent stem cells |journal=Nature Methods |volume=10 |issue=5 |pages=438–444 |doi=10.1038/nmeth.2437 |issn=1548-7091 |pmc=3641175 |pmid=23563795}}</ref><ref>{{Cite patent |number=US10106780B2 |title=Adhesive signature-based methods for the isolation of stem cells and cells derived therefrom |gdate=2018-10-23 |invent1=Singh |invent2=Suri |invent3=McDevitt |invent4=Lu |inventor1-first=Ankur |inventor2-first=Shalu |inventor3-first=Todd Christopher |inventor4-first=Hang |url=https://patents.google.com/patent/US10106780B2/en}}</ref> This work was featured by the director of [[National Institutes of Health|National Institute of Health]], [[Francis Collins]], in his NIH Director's blog.<ref>{{Cite web |last=Collins |first=Dr Francis |date=2013-05-16 |title=Exploiting Stem Cell Stickiness for Sorting |url=https://directorsblog.nih.gov/2013/05/16/exploiting-stem-cell-stickiness-for-sorting/ |archive-url=https://web.archive.org/web/20131025044452/http://directorsblog.nih.gov/2013/05/16/exploiting-stem-cell-stickiness-for-sorting/ |url-status=dead |archive-date=October 25, 2013 |access-date=2024-09-05 |website=NIH Director's Blog }}</ref> Singh then joined [[Cornell University]] as an assistant professor from 2013 to 2019, and was promoted to associate professor with tenure in 2019.<ref>{{Cite web |title=Ankur Singh {{!}} Cornell Engineering |url=https://www.engineering.cornell.edu/about/branding-microsite/independent-thinkers/faculty-stories/ankur-singh |access-date=2024-09-05 |website=www.engineering.cornell.edu}}</ref> In 2020,<ref>{{Cite web |date=2021-05-20 |title=Ankur Singh Joining the Coulter Department as Associate Professor |url=https://bme.gatech.edu/bme/news/ankur-singh-joining-coulter-department-associate-professor |access-date=2024-09-05 |website=bme.gatech.edu }}</ref> he transitioned to the [[Georgia Tech|Georgia Institute of Technology]], where he was an [[Associate professor|Associate Professor]] until 2023, after which he was promoted to professor of Mechanical Engineering and Biomedical Engineering, a position he currently holds. In 2024, Singh was appointed as the Carl Ring Family endowed professor of mechanical engineering.<ref>{{Cite web |title=7 Woodruff School Faculty Members Awarded Professorships {{!}} George W. Woodruff School of Mechanical Engineering |url=https://www.me.gatech.edu/news/7-woodruff-school-faculty-members-awarded-professorships |access-date=2024-09-05 |website=www.me.gatech.edu}}</ref>

Singh is a pioneering researcher and inventor in the field of immune [[organoid]]s, a discipline he has advanced and established as a significant area of scholarly research. His work has established a first synthetic immune organ to understand healthy and diseased immune cells and translate therapeutics.<ref>{{Cite web |title=First functional, synthetic immune organ with controllable antibodies |url=https://www.sciencedaily.com/releases/2015/06/150610175603.htm |access-date=2024-09-02 |website=ScienceDaily }}</ref><ref name=":6">{{Cite web |date=2017-01-16 |title=Engineers Tackle Growing Threat of Infectious Diseases |url=https://www.contagionlive.com/view/engineers-tackle-growing-threat-of-infectious-diseases |access-date=2024-09-05 |website=ContagionLive }}</ref> His research focuses on developing biomaterials-engineered "living" immune tissues, such as organoids and [[Organ-on-a-chip|on-chip]] models, to replicate the structural and functional features of [[lymph node]]s. By applying engineering principles, he investigates the cellular and biophysical interactions between [[Lymphatic system|lymphoid tissues]], immune cells, and tumors. His laboratory explores how immune cells make decisions at the cellular, molecular, and [[Epigenetics|epigenetic]] levels to enhance protection against infections, cancer, and inflammation. Singh has published more than 75 journal articles, 15 issued/pending patents, and more than 95 Keynote and invited talks. Singh has published extensively in the area of immune engineering, biomaterials, hydrogels, nanotechnology, and lymphoma. His work has been published in leading peer-reviewed journals, including ''[[Nature Methods]]'',<ref name=":0" /> ''[[Nature Materials]]'',<ref name=":1">{{Cite journal |last1=Shah |first1=Shivem B. |last2=Carlson |first2=Christopher R. |last3=Lai |first3=Kristine |last4=Zhong |first4=Zhe |last5=Marsico |first5=Grazia |last6=Lee |first6=Katherine M. |last7=Félix Vélez |first7=Nicole E. |last8=Abeles |first8=Elisabeth B. |last9=Allam |first9=Mayar |last10=Hu |first10=Thomas |last11=Walter |first11=Lauren D. |last12=Martin |first12=Karen E. |last13=Gandhi |first13=Khanjan |last14=Butler |first14=Scott D. |last15=Puri |first15=Rishi |date=April 2023 |title=Combinatorial treatment rescues tumour-microenvironment-mediated attenuation of MALT1 inhibitors in B-cell lymphomas |journal=Nature Materials |volume=22 |issue=4 |pages=511–523 |doi=10.1038/s41563-023-01495-3 |issn=1476-4660 |pmc=10069918 |pmid=36928381 |bibcode=2023NatMa..22..511S}}</ref><ref>{{Cite journal |last=Singh |first=Ankur |date=January 2020 |title=Materials modulate immunity and gut microbiome |url=https://www.nature.com/articles/s41563-019-0557-3 |journal=Nature Materials |volume=19 |issue=1 |pages=3–4 |doi=10.1038/s41563-019-0557-3 |pmid=31853034 |bibcode=2020NatMa..19....3S |issn=1476-4660|url-access=subscription }}</ref><ref>{{Cite journal |last1=Lee |first1=Ted T. |last2=García |first2=José R. |last3=Paez |first3=Julieta I. |last4=Singh |first4=Ankur |last5=Phelps |first5=Edward A. |last6=Weis |first6=Simone |last7=Shafiq |first7=Zahid |last8=Shekaran |first8=Asha |last9=del Campo |first9=Aránzazu |last10=García |first10=Andrés J. |date=March 2015 |title=Light-triggered in vivo activation of adhesive peptides regulates cell adhesion, inflammation and vascularization of biomaterials |journal=Nature Materials |volume=14 |issue=3 |pages=352–360 |doi=10.1038/nmat4157 |issn=1476-4660 |pmc=4336636 |pmid=25502097 |bibcode=2015NatMa..14..352L}}</ref> ''[[Nature Nanotechnology]]'',<ref name=":2">{{Cite journal |last1=Yee Mon |first1=Kristel J. |last2=Kim |first2=Sungwoong |last3=Dai |first3=Zhonghao |last4=West |first4=Jessica D. |last5=Zhu |first5=Hongya |last6=Jain |first6=Ritika |last7=Grimson |first7=Andrew |last8=Rudd |first8=Brian D. |last9=Singh |first9=Ankur |date=August 2024 |title=Functionalized nanowires for miRNA-mediated therapeutic programming of naïve T cells |journal=Nature Nanotechnology |volume=19 |issue=8 |pages=1190–1202 |doi=10.1038/s41565-024-01649-7 |issn=1748-3395 |pmc=11330359 |pmid=38684809 |bibcode=2024NatNa..19.1190Y }}</ref><ref>{{Cite journal |last=Singh |first=Ankur |date=January 2021 |title=Eliciting B cell immunity against infectious diseases using nanovaccines |journal=Nature Nanotechnology |volume=16 |issue=1 |pages=16–24 |doi=10.1038/s41565-020-00790-3 |issn=1748-3395 |pmc=7855692 |pmid=33199883 |bibcode=2021NatNa..16...16S}}</ref> ''[[Nature Immunology]]'',<ref>{{Cite journal |last1=Choe |first1=Kibaek |last2=Hontani |first2=Yusaku |last3=Wang |first3=Tianyu |last4=Hebert |first4=Eric |last5=Ouzounov |first5=Dimitre G. |last6=Lai |first6=Kristine |last7=Singh |first7=Ankur |last8=Béguelin |first8=Wendy |last9=Melnick |first9=Ari M. |last10=Xu |first10=Chris |date=February 2022 |title=Intravital three-photon microscopy allows visualization over the entire depth of mouse lymph nodes |journal=Nature Immunology |volume=23 |issue=2 |pages=330–340 |doi=10.1038/s41590-021-01101-1 |issn=1529-2916 |pmc=9210714 |pmid=35087231}}</ref> ''[[Nature Communications]]'',<ref>{{Cite journal |last1=Béguelin |first1=Wendy |last2=Rivas |first2=Martín A. |last3=Calvo Fernández |first3=María T. |last4=Teater |first4=Matt |last5=Purwada |first5=Alberto |last6=Redmond |first6=David |last7=Shen |first7=Hao |last8=Challman |first8=Matt F. |last9=Elemento |first9=Olivier |last10=Singh |first10=Ankur |last11=Melnick |first11=Ari M. |date=2017-10-12 |title=EZH2 enables germinal centre formation through epigenetic silencing of CDKN1A and an Rb-E2F1 feedback loop |journal=Nature Communications |volume=8 |issue=1 |pages=877 |doi=10.1038/s41467-017-01029-x |issn=2041-1723 |pmc=5638898 |pmid=29026085 |bibcode=2017NatCo...8..877B}}</ref> ''[[Nature Reviews Materials]]'',<ref>{{Cite journal |last1=Kim |first1=Sungwoong |last2=Shah |first2=Shivem B. |last3=Graney |first3=Pamela L. |last4=Singh |first4=Ankur |date=June 2019 |title=Multiscale engineering of immune cells and lymphoid organs |journal=Nature Reviews Materials |volume=4 |issue=6 |pages=355–378 |doi=10.1038/s41578-019-0100-9 |issn=2058-8437 |pmc=6941786 |pmid=31903226 |bibcode=2019NatRM...4..355K}}</ref> and ''[[Nature Protocols]]''.<ref>{{Cite journal |last1=Purwada |first1=Alberto |last2=Singh |first2=Ankur |date=January 2017 |title=Immuno-engineered organoids for regulating the kinetics of B-cell development and antibody production |journal=Nature Protocols |volume=12 |issue=1 |pages=168–182 |doi=10.1038/nprot.2016.157 |issn=1750-2799 |pmc=6355337 |pmid=28005068}}</ref> His immune organoids were identified among the Top 100 Discoveries of 2015 by ''Discover Magazine,''<ref>{{Cite web |title=Discover Magazine |url=https://www.discovermagazine.com/magazine/2016/january-february |access-date=2024-09-02 |website=www.discovermagazine.com}}</ref> and were featured in ''[[The Scientist (magazine)|The Scientist]]'' magazine,<ref>{{Cite web |title=Orchestrating Organoids |url=https://www.the-scientist.com/orchestrating-organoids-34896 |access-date=2024-09-05 |website=The Scientist Magazine® }}</ref> and ''Contagion'' news.<ref name=":6" />

In a "News & Views" article featured in ''Nature Nanotechnology'', immunotherapy experts Luca Gattinoni and Dragana Slavkovic-Lukic compared the potential impact of Singh's [[nanowire]] technology on cancer treatment to Neil Armstrong's first step on the moon, suggesting that just as that moment opened new horizons in space exploration, nanowires could revolutionize cancer treatment by advancing naïve T cell-based immunotherapy.<ref name=":2" /><ref>{{Cite journal |last1=Slavkovic-Lukic |first1=Dragana |last2=Gattinoni |first2=Luca |date=August 2024 |title=Nanowires engineer naive T cells for immunotherapy |url=https://www.nature.com/articles/s41565-024-01651-z |journal=Nature Nanotechnology |volume=19 |issue=8 |pages=1085–1086 |doi=10.1038/s41565-024-01651-z |pmid=38802668 |bibcode=2024NatNa..19.1085S |issn=1748-3395|url-access=subscription }}</ref><ref>{{Cite web |title=Nanowires Create Elite Warriors to Enhance T-Cell Therapy {{!}} Research |url=https://research.gatech.edu/nanowires-create-elite-warriors-enhance-t-cell-therapy |access-date=2024-09-05 |website=research.gatech.edu}}</ref> His contributions to the development of organotypic models of lymphoma has further led to discovery that a cancerous lymphoid tumor microenvironment not only promotes lymphoma growth but also diminishes the effectiveness of molecular inhibitors.<ref name=":1" /><ref>{{Cite journal |last1=Gaharwar |first1=Akhilesh K. |last2=Singh |first2=Irtisha |date=April 2023 |title=A synthetic tumour microenvironment |url=https://www.nature.com/articles/s41563-023-01511-6 |journal=Nature Materials |volume=22 |issue=4 |pages=412–413 |doi=10.1038/s41563-023-01511-6 |pmid=36928384 |bibcode=2023NatMa..22..412G |issn=1476-4660|url-access=subscription }}</ref><ref>{{Cite web |title=Groundbreaking Lymphoma Tumor Model Paves Way for New Therapies {{!}} Research |url=https://research.gatech.edu/groundbreaking-lymphoma-tumor-model-paves-way-new-therapies |access-date=2024-09-05 |website=research.gatech.edu }}</ref> His lymphoma tumor models have helped translate lab research findings to Phase I clinical trial of [[Tazemetostat]] in combination with [[Venetoclax]] in patients with relapsed/refractory [[Non-Hodgkin lymphoma|Non-Hodgkin Lymphoma]].<ref>{{Cite journal |last1=Scholze |first1=Hanna |last2=Stephenson |first2=Regan E. |last3=Reynolds |first3=Raymond |last4=Shah |first4=Shivem |last5=Puri |first5=Rishi |last6=Butler |first6=Scott D. |last7=Trujillo-Alonso |first7=Vicenta |last8=Teater |first8=Matthew R. |last9=van Besien |first9=Herman |last10=Gibbs-Curtis |first10=Destini |last11=Ueno |first11=Hideki |last12=Parvin |first12=Salma |last13=Letai |first13=Anthony |last14=Mathew |first14=Susan |last15=Singh |first15=Ankur |date=2020-10-27 |title=Combined EZH2 and Bcl-2 inhibitors as precision therapy for genetically defined DLBCL subtypes |journal=Blood Advances |volume=4 |issue=20 |pages=5226–5231 |doi=10.1182/bloodadvances.2020002580 |pmid=33104794 |issn=2473-9529|pmc=7594393 }}</ref><ref>{{Cite journal |title=ClinicalTrials.gov |url=https://clinicaltrials.gov/study/NCT05618366?tab=history&a=2 |access-date=2024-09-05 |website=clinicaltrials.gov| date=30 May 2024 }}</ref> In addition, he also co-edited biomedical textbook entitled "Microscale Technologies for Cell Engineering", with [[Akhilesh K. Gaharwar]].<ref>{{Cite book |url=https://link.springer.com/book/10.1007/978-3-319-20726-1 |title=Microscale Technologies for Cell Engineering |date=2016 |doi=10.1007/978-3-319-20726-1 |isbn=978-3-319-20725-4 |editor-last1=Singh |editor-last2=Gaharwar |editor-first1=Ankur |editor-first2=Akhilesh K.}}</ref> In 2022, Dr. Singh was nominated, reviewed, and elected by peers and members of the [[American Institute for Medical and Biological Engineering]] (AIMBE) College of Fellows "''for creative integration of biomaterials development and cell manupulations exvivo/in vivo to design synthetic materials for ex vivo immune tissues,"'' an honor reserved for the top 2% of medical and biological engineers globally.<ref>{{Cite web |title=Singh Elected to AIMBE College of Fellows {{!}} George W. Woodruff School of Mechanical Engineering |url=https://www.me.gatech.edu/news/singh-elected-aimbe-college-fellows |access-date=2024-09-02 |website=www.me.gatech.edu}}</ref><ref name=":3">{{Cite web |title=Ankur Singh, Ph.D. COF-7119 - AIMBE |url=https://aimbe.org/college-of-fellows/COF-7119/ |access-date=2024-09-02 }}</ref>

He has received funding from the [[National Institutes of Health|National Institute of Health]], [[National Science Foundation]], Wellcome Leap HOPE,<ref name=":4" /> [[United States Department of Defense|US Department of Defense]],<ref name=":5">{{Cite web |title=Singh wins grant from defense department for cancer research {{!}} Cornell Chronicle |url=https://news.cornell.edu/stories/2017/05/singh-wins-grant-defense-department-cancer-research |access-date=2024-09-05 |website=news.cornell.edu }}</ref> [[Defense Threat Reduction Agency]], and the Curci Foundation.<ref>{{Cite web |title=2022 Research Grants – Shurl and Kay Curci Foundation |url=https://curcifoundation.org/research-grants/2022-research-grants/ |access-date=2024-09-02 }}</ref> In 2021, Singh was selected by Wellcome Leap HOPE, a global Advanced Research Projects Agency for Health,<ref>{{Cite web |title=Homepage |url=https://wellcomeleap.org/ |access-date=2024-09-02 |website=Wellcome Leap: Unconventional Projects. Funded at Scale. }}</ref> to lead a team of researchers from the Georgia Institute of Technology and Emory University, as part of the nonprofit's international $50 million Human Organs, Physiology, and Engineering (HOPE) program.<ref name=":4">{{Cite web |date=2021-05-20 |title=Wellcome Leap Grant Funds Work to Create Human Immune Responses |url=https://bme.gatech.edu/bme/news/wellcome-leap-grant-funds-work-create-human-immune-responses |access-date=2024-09-02 |website=bme.gatech.edu }}</ref> Singh is an associate editor of scientific journals Science Advances,<ref>{{cite web | url=https://www.science.org/content/page/science-advances-editorial-working-groups | title=Editorial Working Groups }}</ref> Biomaterials,<ref>{{Cite web |title=Editorial board - Biomaterials {{!}} ScienceDirect.com by Elsevier |url=https://www.sciencedirect.com/journal/biomaterials/about/editorial-board |access-date=2024-09-02 |website=www.sciencedirect.com}}</ref> and Cellular and Molecular Bioengineering.<ref>{{Cite web |title=Cellular and Molecular Bioengineering |url=https://link.springer.com/journal/12195/editors |access-date=2024-09-02 |website=SpringerLink }}</ref> He serves on the Executive Advisory Board of Advanced NanoBiomed Research,<ref>{{Cite web|url=https://onlinelibrary.wiley.com/page/journal/26999307/homepage/editorial-board|title=Advanced NanoBiomed Research Editorial Advisory Board}}</ref> and served as an Associate Scientific Advisor for Science Translational Medicine for 2018-2019, where he wrote editor's choice articles.<ref>{{Cite journal |last=Singh |first=Ankur |date=2019-01-16 |title=T cells, the last samurai against humoral rejection in lung transplants |url=https://www.science.org/doi/10.1126/scitranslmed.aaw5313 |journal=Science Translational Medicine |volume=11 |issue=475 |article-number=eaaw5313 |doi=10.1126/scitranslmed.aaw5313 |issn=1946-6234|url-access=subscription }}</ref><ref>{{Cite journal |last=Singh |first=Ankur |date=2018-11-14 |title=Charting the course of metastatic cells |url=https://www.science.org/doi/10.1126/scitranslmed.aav9142 |journal=Science Translational Medicine |volume=10 |issue=467 |article-number=eaav9142 |doi=10.1126/scitranslmed.aav9142 |issn=1946-6234|url-access=subscription }}</ref><ref>{{Cite journal |last=Singh |first=Ankur |date=2018-09-19 |title=Send in the decoys: Cell-like particles ameliorate inflammatory autoimmune arthritis |url=https://www.science.org/doi/10.1126/scitranslmed.aav0341 |journal=Science Translational Medicine |volume=10 |issue=459 |article-number=eaav0341 |doi=10.1126/scitranslmed.aav0341 |issn=1946-6234|url-access=subscription }}</ref><ref>{{Cite journal |last=Singh |first=Ankur |date=2018-07-25 |title=Convection-enhanced delivery of drugs for deadliest pediatric brain tumors |url=https://www.science.org/doi/10.1126/scitranslmed.aau7380 |journal=Science Translational Medicine |volume=10 |issue=451 |article-number=eaau7380 |doi=10.1126/scitranslmed.aau7380 |issn=1946-6234|url-access=subscription }}</ref><ref>{{Cite journal |last=Singh |first=Ankur |date=2018-05-30 |title=Bactericide hydrogel prevents orthopedic implant infections |url=https://www.science.org/doi/10.1126/scitranslmed.aau0463 |journal=Science Translational Medicine |volume=10 |issue=443 |article-number=eaau0463 |doi=10.1126/scitranslmed.aau0463 |issn=1946-6234|url-access=subscription }}</ref><ref>{{Cite journal |last=Singh |first=Ankur |date=2018-04-04 |title=Targeting a conserved epitope: A new chink in malaria's armor |url=https://www.science.org/doi/10.1126/scitranslmed.aat3890 |journal=Science Translational Medicine |volume=10 |issue=435 |article-number=eaat3890 |doi=10.1126/scitranslmed.aat3890 |issn=1946-6234|url-access=subscription }}</ref><ref>{{Cite journal |last=Singh |first=Ankur |date=2018-02-07 |title=No one is naïve: Young infant's immunity can dodge Darwinian selection |url=https://www.science.org/doi/10.1126/scitranslmed.aar7530 |journal=Science Translational Medicine |volume=10 |issue=427 |article-number=eaar7530 |doi=10.1126/scitranslmed.aar7530 |issn=1946-6234|url-access=subscription }}</ref>

Singh is known for his commitment to fostering a collaborative learning environment and encouraging students to engage in interdisciplinary research. He teaches a variety of courses related to fundamentals of biomedical engineering to specialized courses in biomaterials, biofluid mechanics, tissue engineering, and immunoengineering. For his pedagogy, he has received Georgia Tech Student Recognition of Excellence in Teaching Award (2023) and John Swanson '61 ME Teaching Excellence Award from Cornell Engineering (2017).<ref>{{Cite web |last=Harris |first=Bethany |date=2024-02-02 |title=Georgia Tech 2023 CIOS Award Winners |url=https://blog.ctl.gatech.edu/2024/02/02/georgia-tech-2023-cios-award-winners/ |access-date=2024-09-02 |website=On Teaching and Learning @ Georgia Tech }}</ref><ref>{{Cite web |title=Congratulations to Professor Ankur Singh for being a recipient of the 2016-2017 Excellence in Teaching Award {{!}} Sibley School of Mechanical and Aerospace Engineering |url=https://www.mae.cornell.edu/news/congratulations-professor-ankur-singh-being-recipient-2016-2017-excellence-teaching-award |access-date=2024-09-02 |website=www.mae.cornell.edu}}</ref> An advocate of work-life balance in academic career, in 2024 Singh shared with [[Nature (journal)|Nature]] how he is thriving in academia and what fuels his passion for it.<ref>{{Cite journal |last=Landhuis |first=Esther |date=2024-03-12 |title=11 reasons why we've stayed in academia |url=https://www.nature.com/articles/d41586-024-00724-2 |journal=Nature |volume=627 |issue=8003 |pages=453–454 |doi=10.1038/d41586-024-00724-2|pmid=38472329 |bibcode=2024Natur.627..453L |url-access=subscription }}</ref>

== Awards ==
* 2022: Fellow of [[American Institute for Medical and Biological Engineering]]<ref name=":3" />
* 2022: Society for Biomaterials Mid Career Award
* 2017: Member of the [[National Academy of Engineering]] EU-US Frontiers of Engineering (EU-US FOE)<ref>{{Cite web |title=Ankur Singh |url=https://dev.naefrontiers.org/184435/Ankur-Singh |access-date=2024-09-02 |website=dev.foe.diamax.com}}</ref>
* 2017: Department of Defense Congressionally Directed Medical Research Programs Career Award<ref name=":5" />
* 2017: Society for Biomaterials Young Investigator Award<ref>{{Cite web |title=Singh honored as top young investigator by biomaterials society {{!}} Cornell Chronicle |url=https://news.cornell.edu/stories/2016/12/singh-honored-top-young-investigator-biomaterials-society |access-date=2024-09-05 |website=news.cornell.edu }}</ref>
* 2016: US [[National Science Foundation]] CAREER Award (DMR: BMAT)<ref>{{Cite web |title=NSF Award Search: Award # 2034202 - CAREER: DYNAMIC LIVING HYDROGEL NETWORKS FOR SPATIO-TEMPORAL CONTROL OF CELL SIGNALING |url=https://www.nsf.gov/awardsearch/showAward?AWD_ID=2034202 |access-date=2024-09-02 |website=www.nsf.gov}}</ref>

== References ==
<references />

{{DEFAULTSORT:Singh, Ankur}}
[[Category:Living people]]
[[Category:Cornell University faculty]]
[[Category:Georgia Tech faculty]]
[[Category:American biomedical engineers]]
[[Category:American scientists of Asian descent]]
[[Category:Scientists from Georgia (U.S. state)]]
[[Category:Year of birth missing (living people)]]

Ankur Singh - Revision history

DigitalKush: made some biography v1...